BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation continues to expand its suite of patient-driven eData products and services and advances the concept of “BYOD” – Bring Your Own Device – for eClinical research. PHT announced the NetPRO™ System is now available, optimized and validated for use by clinical trial patients and clinicians on the Apple iPad platform. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.
NetPRO is a web-based system for collecting patient and clinician outcomes data for label claims and post market research. The iPad’s simple design and ease of use for patients and clinicians alike makes it an ideal platform for clinical data collection. NetPRO offers researchers the ability to collect clinical outcomes data economically and efficiently and in accordance with the FDA PRO Guidance.
“More clinicians and doctors use the iPad than any other tablet. Sponsors have been requesting PHT to offer NetPRO on the iPad platform for clinicians and patients alike especially in observational research. PHT is pleased to add the iPad and Safari browser to the list of NetPRO validated platforms,” said Sheila Rocchio, Vice President of Marketing and Product Management at PHT.
To hear more about the latest PHT roadmap and case studies, innovations and best practices about PROs and eCOA Strategy and Systems, register for the 2014 PRO & eCOA Congress at bit.ly/16EYVSg. PHT invites all Congress alumni to join the exclusive PRO & eCOA Congress LinkedIn Community to exchange information, ideas and experiences throughout the year.
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical outcome assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks™ online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 650+ global trials resulting in 16+ regulatory approvals. PHT Clinical Science and Consulting offers the scientific, regulatory, and technological expertise today’s eCOA market demands and patients deserve. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter, Google+ and YouTube.
